Dei Biopharma gets NDA clearance for drugs manufacturing
KAMPALA, UGANDA - Dei Biopharma Limited has been granted a landmark license by the National…
5 days ago
Dei Biopharm Vaccines Plant seeks UGX 1.8 trillion from government
Dei Group chief Dr. Magoola thanks President Museveni after Ph.D. award
KAMPALA – Dr. Matthias Magoola, the founder and Chief Executive Officer of Dei Group of…
3 months ago
Dei Group Founder Magoola awarded PhD in Management
KAMPALA/PARIS — Matthias Magoola, the founder and Chief Executive Officer of Dei Group of Companies,…
3 months ago
Inside Uganda’s Dei BioPharma vaccines plant
Low cost drugs. The multi-million dollar biological drugs and vaccines manufacturing facility in Mattuga, Wakiso,…
11 months ago
Breakthrough as Uganda Government ‘agrees’ to inject UGX 1.8 trillion in Magoola’s Dei Biopharm Vaccines Plant
MATUGGA —Uganda risks losing the chance to become the centre of vaccine production in Africa…
1 year ago